The PRWIRE Press Releases https:// 2021-04-01T07:33:47Z Five Reasons Why You Should Choose ELDO 2021-04-01T07:33:47Z five-reasons-why-you-should-choose-eldo ELDO provide a large selection of Nitrile examination gloves, Vinyl examination gloves, Latex examination gloves, and Plastic gloves. They also supply Wet wipes, Dry wipes packed in plastic bags and plastic bottles, and here are five reasons why you should choose ELDO for your PPE supplies, starting with their professional experience.      ELDO have 20 years in the production and distribution in the disposable gloves and wipe industry. Secondly, they provide very competitive prices, with automatic   production lines and well trained workers to optimise efficiency and reduce cost greatly. ELDO support you to be the most competitive distributor in your region.    Thirdly, their short lead times, supported by more than 300 well-trained workers in ELDO’s factories, and more than 1000 containers exported annually. They are professional and flexible according to your requirements.    Number four are their multi solutions. Their knowledge of the local market, combined with their production plans, will support you to have multi solutions of the purchasing plan, and finally, their customer service. Top sales with professional skills will help you feel that is is always easy to communicate with a factory. All ELDO staff will stand by you, reply to your inquiry and solve your problems, no matter pre-sales or after-sales.    For 20 years ELDO’s business has grown through providing a very high level of service, quality and dedication to their customer needs, and their comprehensive range of products saves you time and money and enables you to buy from one supplier. Now they supply their high-quality products in around 1000 containers annually to more than 55 countries.     As they say, “On behalf of the ELDO team, we look forward to offering you our outstanding service in the near future”, and for more information on disposable dry wipes, disposable PE aprons and disposable sterile gloves please go to .  Australians rate the nation's healthcare in first Australian Healthcare Index report 2021-04-01T03:11:10Z australians-rate-the-nation-s-healthcare-in-new-australian-healthcare-index-report Despite a once-in-a-century pandemic still lingering one year on, Australians have given a vote of confidence to the Australian healthcare system with 65.5% rating it a score of 8 or above out of 10 in a new report capturing the points of view of Australian patients.   The first Australian Healthcare Index report seeks to elevate patient perspectives and experiences on overall healthcare in Australia, based on responses from over 8000 adults.   Produced by the Australian Patients Association and HealthEngine, the report captures learnings from patients on the public and private healthcare ecosystem including primary care, private health insurance (PHI), emergency departments, elective surgery, prescription medicine and more.   Designed to provide a pulse check on healthcare in Australia, key findings include: ●      Patients rated Australian Healthcare 7.8 out of 10 ●      Patients are more likely to recommend their GPs than their dentist to friends and colleagues ●      While 55.1% of respondents have Private Health Insurance, the majority are not recommending their PHI and many feel it costs too much ●      36.6% think prescription medicine is too expensive ●      Nearly 95% embrace the intersection of healthcare and tech with the use of and interest in telehealth, health apps, online booking, e-scripts and more   HealthEngine CEO, founder and medical director Dr Marcus Tan says the report is testament to the robustness of the healthcare system.   “The fact a majority of Australians have a favourable opinion of the healthcare system after COVID-19 caused disruption, is a credit to the thousands of healthcare professionals with a commitment to patient-centred care.'' said Dr Tan.  “With the release of the Australian Healthcare Index, we can identify, share and champion people’s perspectives on healthcare, as well as provide a baseline of learnings to establish a report that will come out twice a year.”   Dr Tan added, “Working closely with the APA, we hope the report drives conversation and consideration for the continued support of a patient-centric approach to healthcare.”   Stephen Mason, CEO of the Australian Patients Association hopes the report will help strengthen patient-centred care in the healthcare system. “As we advocate for improved patient care and health outcomes, the Australian Healthcare Index is an important pulse check on the patient experience for organisations like ours as well as the greater healthcare community, peak bodies and government at all levels, who are contributing to and leading public and private healthcare in Australia,” said Mason.   “The APA became involved with the Australian Healthcare Index to hear the patient’s voice. Although we are comforted by the knowledge that our healthcare system has coped well during the pandemic, we are concerned about dental care and the cost of medicines.”   “As for the perceived lack of value from PHI, we are working closely with Private Healthcare Australia and its members to address this concern and in particular to prevent excessive out of pocket costs. “We hope the report’s findings make a positive contribution to shaping national healthcare policy, on behalf of patients across the country."   View or download the Australian Healthcare Index at  An interactive dashboard is available to explore the national survey results and view data at a state level or other demographics.    -end- About HealthEngineHealthEngine is Australia’s largest consumer healthcare network and the #1 go-to for healthcare bookings. Founded in 2006, HealthEngine is on a mission to transform Australia’s healthcare by making it easier for people to connect with their healthcare providers online and for health practitioners to deliver a great patient experience through technology. More than 9 million people across Australia have made more than 47 million bookings on the platform.   About the Australian Patients Association The Australian Patients Association is an independent not-for-profit organisation established to promote and protect the rights and interests of patients, and improve overall patient outcomes. We will address important health issues impacting on patient care in the public and private healthcare system.  We will research and develop sensible remedies to benefit all our supporters and the broader community. The Australian Patients Association also seeks to educate patients about their rights and choices, as well as supporting patients in need. 50th Anniversary: Invention of GTIN-the Number Behind the Barcode 2021-03-29T23:47:51Z 50th-anniversary-invention-of-gtin-the-number-behind-the-barcode Fifty years ago, on 31 March 1971, leaders from the biggest names in commerce came together and transformed the global economy forever by developing the Global Trade Item Number (known as the 'GTIN'). This numerical code uniquely identifies every single product and is the core of the barcode, the most important supply chain standard in history. Today, the barcode is scanned over six billion times every day and remains one of the most trusted symbols in the world.Maria Palazzolo, Executive Director and Chief Executive Officer of GS1 Australia said, "I firmly believe that the digitalisation of the GTIN is one of the most significant milestones in the life of our organisation."From the linear EAN/UPC barcode to 2DBarcodes, the need to capture more than just product and pricing information is becoming more urgent and increasingly important. In order to do this successfully we must bring industry together to collaborate and to harmonise. The journey into the future has well and truly begun."GS1 standards such as the barcode continue to help make the vast complexity of modern, global business flow quickly, efficiently and securely, simplifying all kinds of supply chain processes in almost every sector all around the world. However, as consumers demand more and better product information, it is time to bring barcodes to the next level. Developments towards next-generation barcodes (for example square barcodes like QR codes), which can hold vastly more information, should be used to empower consumers with trusted information and reshape global commerce, just as the GTIN did half a century ago.50 years agoThe 1971 historic meeting took place in New York City and included leaders from the biggest names in groceries, retail and consumer goods at the time, including Heinz, General Mills, Kroger and Bristol Meyer. The executives agreed to create a system to uniquely identify every single product, calling it the Global Trade Item Number, or GTIN. With great foresight, they believed that the GTIN could have a positive impact even beyond the grocery store - from warehouses to board rooms - and would boost speed and efficiency of transactions and processes that could transform everything from supply chains to consumer experiences. And they agreed at the meeting to continue to innovate together to create a system that would benefit businesses and consumers alike. Decades later, the BBC named the resulting outcome one of "the 50 things that made the world economy." More information and quotes are in the attached media release.TO INTERVIEW Maria Palazzolo, Executive Director and Chief Executive Officer, GS1 Australia or Marcel Sieira, Chief Customer Officer, GS1 Australia please contact: Marian Makram-Perkins, T: 03 8581 5940 E: marian.makram-perkins@gs1au.orgAbout GS1 Australia GS1 is a neutral, not-for-profit organisation that develops and maintains the most widely used global standards for efficient business communication. We are best known for the barcode, named by the BBC as one of "the 50 things that made the world economy". GS1 standards and services improve the efficiency, safety and visibility of supply chains across physical and digital channels in 25 sectors. With local Member Organisations in 114 countries, 2 million user companies and 6 billion transactions every day, GS1 standards create a common language that supports systems and processes across the globe. For more information visit the GS1 Australia website: Kinima Physio and Snap Fitness Form Alliance for a Richer Client Experience 2021-03-22T07:38:12Z kinima-physio-and-snap-fitness-form-alliance-for-a-richer-client-experience Rob O’Mahony and Alina Tran, directors of Kinima Physio West Leederville, are excited to announce a new and exciting collaboration with Snap Fitness West Leederville. The alliance will provide a better client experience with a strong sense of community. Kimima Physio is a modern and fresh physiotherapy clinic. Snap Fitness is a 24-hour gym and fitness centre that shares very similar values to Kinima Physio. “We currently see clients that are also members of Snap Fitness West Leederville and are extremely happy with the service that Alicia and her amazing team provide,” said O’Mahony. “The members are impressed with the convenience, atmosphere, equipment, group fitness classes, and the availability of multiple training zones.” Rob and Alina are also pleased to announce that they will be offering Snap Fitness West Leederville members $20 off all initial appointments at Kinima Physio West Leederville for the foreseeable future. Kinima Physio clients will be entitled to a special deal for gym membership with a zero joining fee, the first month free, and a half price access card. Kinima Physio West Perth also collaborated recently with Body Fit Training West Perth. Kinima Physio can help the BFT West Perth members with sports physio, orthopaedic rehabilitation, clinical Pilates and exercise rehabilitation, dry needling, sports massage, and running assessments. Kinima Physio Subiaco has a mission to keep their clients exercising while recovering from injuries using a combination of a hands on and active approach to physiotherapy. Kinima Physio Wembley prides itself on being passionate about their special interests of sports physio, shoulder physio, knee physio, and lower back pain. Rob and Alina are looking forward to Snap Fitness West Leederville joining the Kinima Physio community to help individuals continue living an active and meaningful life. About Kinima Physio At Kinima Physio, we integrate clinical excellence with a unique client experience to create a local health movement that empowers as many people as possible. With 25 years of combined experience in the physiotherapy and health industries, including elite sports and orthopaedics, we offer the latest evidence-based treatment programs to instill clarity and understanding, restore function and confidence, and drive high performance. Connect with us on Instagram and Facebook. Media Contact Kinima Physio Rob O’Mahony - Director Shop 4/110 Cambridge St. West Leederville WA 6007 Australia Website: MedicalDirector and HealthEngine Launch Official Integration across Helix, Clinical and Pracsoft 2021-03-19T02:38:18Z medicaldirector-and-healthengine-launch-official-integration-across-helix-clinical-and-pracsoft 19-03-21 –Sydney and Perth -- MedicalDirector and HealthEngine have today announced their partnership to deliver a fully integrated patient engagement solution within leading health software, MedicalDirector Helix, Clinical and Pracsoft. The partnership enables practices to securely manage HealthEngine appointment bookings, recalls and reminders, as well as COVID-19 vaccinations with the integration of HealthEngine’s COVAX online booking solution and MedicalDirector’s health software. With the partnership, HealthEngine joins the MedicalDirector Marketplace — an accredited partnership program that delivers secure, validated and complementary tools to enable patient satisfaction and practice efficiency.  “Adding HealthEngine as a trusted Marketplace partner, allows us to deliver a shared vision, focused on security, convenience and the power of interoperability. This work demonstrates this mutual commitment to GP practices across Australia,” said Matthew Bardsley, MedicalDirector CEO.  “With this partnership, we’re responding to market needs and what we hear from our practice owners, GPs and practice managers, to help them manage their practice, while they focus on patient care.” The integration offers powerful benefits for practice owners, practice managers and GPs. The more integrated booking process for both providers and patients is designed to drive patient connections and increase practice growth, by providing practices with more visibility to patients, with 24/7 appointment booking on HealthEngine’s website and app.  “With COVID-19 as the catalyst, more practices are looking for versatile solutions to take work beyond the clinic walls. Overall, our integration with MedicalDirector cloud and desktop-based software, gives GP practice leaders access to HealthEngine’s marketplace to reach more patients, fill books and grow along with our online booking system,” said Dr Marcus Tan, HealthEngine CEO, Founder and Medical Director.   ### About MedicalDirector MedicalDirector is a leading primary healthcare technology company that for over 25 years has provided innovative, proprietary software solutions that help General Practice (GP) and specialist medical practices deliver care to their patients. Our software platform integrates seamlessly to enable faster and more collaborative workflows in medical practices and connectivity into the broader healthcare system. Approximately 23,000 clinicians use MedicalDirector to manage and deliver 80+ million patient consultations per year, across small and large medical practices. Key software features include practice management, clinical health records, medical billing, reporting, referral management and patient engagement. Today, MedicalDirector is a first-mover in innovative, cloud-based healthcare software through Helix, and in delivering customisable solutions for medical professionals in Australia and now in the United Kingdom. The comprehensive suite of solutions utilises the latest tools and technologies to simplify workflows and enable interoperability across healthcare systems. With MedicalDirector, medical practices can manage higher patient volumes, improving productivity and providing doctors the flexibility to deliver care anytime, anywhere on any device. About HealthEngine HealthEngine is Australia’s largest consumer healthcare network and the #1 go-to for healthcare bookings.  Founded in 2006, HealthEngine is on a mission to transform Australia’s healthcare by making it easier for people to connect with their healthcare providers online and for health practitioners to deliver a great patient experience through technology.  More than 9 million Australians have made more than 47 million bookings on the platform. To find, book and manage medical and dental appointments, visit For healthcare providers, please visit to learn more and join Australia’s largest network of patients.  Microba Life Sciences partners with Unilever to target sleep through the gut microbiome 2021-03-15T23:19:07Z microba-life-sciences-partners-with-unilever-to-target-sleep-through-the-gut-microbiome Australia, 16 March 2021 – Experts in gut microbiome analysis, Microba Life Sciences, is empowering global consumer goods company Unilever to take a novel approach to this problem by exploring the links between sleep and the human gut with the aim to improve sleep for people across the globe.  The study will look at associations between the gut microbiome and sleep, with current data indicating that gut bacteria is involved in sleep quality, the regulation of circadian rhythms and the production of natural substances that aid in the promotion of sleep.   As a part of Unilever’s Future Food ambition, Unilever wants to play a role in helping people transition towards healthier diets and has committed to doubling the number of products delivering positive nutrition globally, by 2025.   The aim of the project is to utilise Microba’s database which cross references diet, lifestyle and sleep habits to discover associations that could help improve sleep. Microba is building the world’s largest consistently collected and analysed dataset of de-identified gut microbiome metagenomic data which is providing unparalleled insight into the role of the microbiome in human disease. This database will be leveraged to discover associations between the gut microbiome, nutrition and sleep. Unilever are interested to see whether the results can be applicable across their food and refreshments portfolio in the future. Dr Kylie Ellis, Research Manager at Microba, said that the project would advance research in the links between the gut microbiome and human physiology for the promotion of sleep and other gut-brain axis functions.    “We look forward to working with Unilever to understand more about the way that diet, lifestyle and gut bacteria influences sleep habits and quality of rest,” she said.   Born from ground-breaking research by Co-founders Professors Phil Hugenholtz and Gene Tyson, Microba is leading the way in precision microbiome analysis using metagenomics pioneered by the duo. This research is powering discoveries for greater advancements in human health.Ends. About Microba Life Sciences   Microba Life Sciences is a precision microbiome science company working to transform human health through their world-leading technology in analysing the microbiome. Microba’s proprietary analysis platform enables researchers to reveal important connections and make new discoveries with accurate measurement of the gut microbiome.  Powered by precision analysis, Microba’s end-to-end support includes a validated sample collection method, shotgun metagenomic sequencing and leading bioinformatics analysis. [1] COVID-19 event - 2nd GS1 Executive Dialogue on 18 March 2021-03-14T22:51:30Z covid-19-event-2nd-gs1-executive-dialogue-on-18-march Following the success of the first international GS1 Executive Dialogue, the second edition is happening on 18 March at 11pm AEST (other times below) and features top contributors from Ireland, Turkey and New Zealand. The event will be moderated by Deloitte. Participants will hear about practical experiences and recommendations for the use of global standards to achieve a safe and efficient distribution and administration of Covid-19 vaccines.Details of the 1-hour online event can be found here (which includes a recording of the first Executive Dialogue): event page and here’s the registration page. Other times below. 2021 World’s Greatest Shave like no other as Aussies take to TikTok, mow their mullets, and seek a fresh start in a COVID climate 2021-03-10T01:51:26Z 2021-world-s-greatest-shave-like-no-other-as-aussies-take-to-tiktok-mow-their-mullets-and-seek-a-fresh-start-in-a-covid-climate 2021 is proving to be a year like no other for the Leukaemia Foundation’s iconic World’s Greatest Shave, with an astounding number of shavers harnessing the power of social media platforms to lop off their locks and sacrificing some larger-than-life hairstyles to support Australians with blood cancer.As ‘Shave Week’ (March 10-14) kicks off, the Leukaemia Foundation has its sights set on raising $15 million through World’s Greatest Shave (#worldsgreatestshave / #shaveforacure / #shavechallenge) to provide vital support for the growing number of Australians diagnosed with blood cancer including leukaemia, lymphoma, myeloma and other blood related disorders. In a week when Australians would usually pack out clubs, pubs, workplaces, schools and malls across the country to cheer on thousands of brave shavers, Leukaemia Foundation CEO Chris Tanti said the COVID-19 pandemic and crowd restrictions have instead prompted shavers to reimagine their campaign, reassess what they’re willing to lose and think outside the box to connect with others and smash their fundraising targets.“As Australians continue feeling the effects of COVID-19, we’re seeing a massive and unique shift in the way the community is engaging with World’s Greatest Shave this year – swapping shopping centres for shaves on screen, and going that extra mile by growing - and losing - some lengthy mullets and manes. It really is a year like no other for this iconic event,” he said.“We’ve been experiencing some extraordinary digital engagement with the campaign, with more than 9 million views of World’s Greatest Shave user generated content using tags like #worldsgreatestshave on TikTok alone, plus a significant rise in engagement through Instagram and Facebook, so clearly Australians are embracing trending social platforms to spread the word about their shaves in a new way we’ve never seen before.“Not only that, why people are shaving and the volume of hair being shaved is changing too – after the year that was 2020, we’re definitely seeing a number of Australians chasing ‘a fresh start’ and shaving their heads to symbolise this, however long their locks, or fearlessly donning an eyebrow-raising ‘do’ to capture community attention and garner support for their shave. The result is some unique approaches, and some brilliant outcomes. “In the 23rd year of this beloved campaign, we’re thrilled and extremely grateful that the national community is continuing to show up, support, and celebrate the World’s Greatest Shave with us and seeking new and inspiring ways to do so in a changing world.”Mr Tanti is joining with what is expected to be around 20,000 Australians participating in World’s Greatest Shave this year, utilising social media to share the moment he loses his locks at the Leukaemia Foundation ESA Village in Brisbane. “With 47 Australians diagnosed with blood cancer every day and that number set to double to close to 100 by 2035, there has never been a more important time to get behind World’s Greatest Shave, and I’m proud to be joining the army of Australians shaving their head as we all keep up the fight against this deadly set of diseases,” he said. Blood cancer does not discriminate. It can develop in anyone, occur at any age from newborns to older Australians across all states and territories. Sadly, there are no screening programs available for blood cancers and there is no way to prevent blood cancer through lifestyle change.     Mr Tanti said blood cancer symptoms can sometimes be subtle or similar to other conditions such as a virus, often making it a silent disease that can be tricky to catch - but if it remains unchecked, the consequences can be devastating. “We also know Australians living with blood cancer are particularly susceptible to COVID-19, and as a result the Leukaemia Foundation has more than doubled support over the past year as those diagnosed continue to ride the emotional and mental roller coaster of the pandemic.“By signing up to World’s Greatest Shave and raising money, you can help ensure that the growing number of families facing blood cancer have someone to turn to every step of the way in their journey, a place to call home during treatment, and access to the best possible care.”World’s Greatest Shave is the single biggest source of funds that enable the work of the Leukaemia Foundation each year. Not only does the money raised support families impacted by blood cancer, but it also helps the brilliant research scientists continue their search for better ways to diagnose and treat blood cancer more effectively. “Shaving is the ultimate act of solidarity with Australians living with blood cancer. Every year, thousands of brave heroes send a powerful message of hope to those diagnosed, and this year that message is ringing especially loud and clear. Whether you have a personal connection to cancer, wish to tick an item off your bucket list or simply want to raise money for a good cause, we urge you to sign up to World’s Greatest Shave or donate to someone who has, and make 2021 the year that you help to make a significant difference,” Mr Tanti said.To help shave the world from blood cancer, simply download the World’s Greatest Shave app, sign up online at or call 1800 500 088 for more information. #worldsgreatestshave #shaveforacure #shavechallenge   *ENDS* Healthcare sector should reach out to technology scale-ups 2021-03-09T02:45:48Z healthcare-sector-should-reach-out-to-technology-scale-ups For immediate release 9 March 2021 Healthcare sector should reach out to technology scale-ups The COVID-19 pandemic accelerated the use of technology and opened opportunities for the industry, but also showed us that we need to make some critical changes.  It is now clear that the future of healthcare organisations depends on their ability to change, increase agility, and develop resilience continually. Success in the new normal means taking the opportunity to design the future of the organisational culture. And there is no better sector to learn from than technology scale-up leaders who survive and prosper in an environment requiring constant transformation.   Why scale-ups? Spending most of my career with scale-ups and joining a hospital board during COVID-19, has opened my eyes to the lessons healthcare leaders can learn from scale-ups within the innovation ecosystem.COVID-19 forced the health industry to undergo a change in a capacity it hasn’t encountered before. It is not a one-off change, but a new paradigm that compels healthcare industry leaders to question the agility and scalability of their organisations now and into the future. While immunisation research is undergoing significant progress, the pandemic is unlikely to disappear, nor be the last one. Health organisations are now required to adopt a different leadership model and develop an organisational culture that supports constant changes, agility and resilience.  During the lockdown in Melbourne hospitals and other health organisations experienced operating on the continuum that many scale-ups live in: some operations needed to scale up fast, while others were on hold. For example, there was a period with a delay of non-essential elective surgeries, while at the same time, some hospitals had to double and even triple their ICU capacity. Now, when there is a long queue for elective surgeries, there is a need to scale up these services. These activities involved training, restructuring work arrangements and procedures, overloading the system and putting immense pressure on the entire team. Scale-up leaders are used to operating in such environments. Scale-ups do not run on a  linear growth, where the company adds new resources and its revenue increases as a result. Scaling is often achieved without a substantial increase in resources. The scale is achieved by increasing service and revenue without incurring a higher cost.  Core challenges scale-ups, and the health sector share include: Technological changes - scale-ups operate in a challenging competitive landscape and constant technological changes that require regular adjustments and at the same time opens windows to new business opportunities.  The accelerated introduction of telehealth services during the pandemic, questions the traditional way health professionals are used to working, but also presented them with exciting prospects. Employee shortages- scale-ups operate in a talent shortage environment (such as lack of qualified engineers); the health and aged care sectors were also challenged by employee shortages, as well as from an ageing workforce. Both sectors have a working environment that can be highly stressful, and hence they need to deal with workforce burn-out and retention issues. Team upskilling - due to the skills shortage and the fast changes in technologies, scale-ups are in a constant need to upskill their teams. The health sector now needs to upskill their workforce with digital and technological capabilities to cater for telehealth and other technological advancements, such as artificial intelligence and automation. Organisational culture- scale-ups have a short window of opportunity, and they have to ensure they deliver before the window is closed. Producing innovative solutions on time and budget means proactively leading the organisational culture, supporting the team and communicating the “why” (mission). When employees do not buy into the company’s mission, they are often not engaged. Employees in the health sector choose their profession for the “why”, but the industry as a whole tends to pay less attention to proactively leading the organisational culture. In both sectors, when culture is a problem, employee turnover is on the rise, and customer satisfaction is suffering. Leading on the stagnation-accelerated growth continuum Scale-ups navigate their way on a growth continuum between stagnation and acceleration. They deliver services and products under constant business barriers (financial, talent, infrastructure, market access and leadership capacity) and operational constraints (changes in goals and priorities, lack of resources, team instability, ineffective structure and lack of processes).To successfully operate on this continuum, scale-up leaders must develop scalable processes and invest in their organisational culture and employee’s development. Adopting different people, culture and leadership perspectives It is fair to claim that the pandemic caught us all by surprise and unprepared. The silver lining in this crisis is that it has accelerated processes in the healthcare industry, such as the use of telehealth in a way that there is no going back. Now it is time for leaders to stop and reflect and ensure they learn from the journey and shape their organisations powerfully to the future. Now is the time for them to develop a culture that allows their organisations to change, increase agility, and build resilience continually. These are not small cosmetics, but in many cases, we are talking about significant systematic changes combining strategic thinking, culture, workforce, leadership and agile processes.  Scale-up leaders can offer their healthcare colleagues insights in regard to how to lead an organisational culture that supports constant changes and innovations; operation and how to build agility into processes when continually moving on the growth continuum between stagnation and acceleration; how to develop the leadership team to think strategically about opportunities as well as how to build high performing multidisciplinary ad-hoc teams. There is no better time than now to reflect on healthcare sector and implement the changes that need to be made. Dr Zivit Inbar is the founder and CEO of DifferenThinking, a consulting practice that specialises in people, culture, leadership and performance strategies for growth. HealthEngine chosen to build the Commonwealth booking platform as part of the COVID-19 Vaccination Information and Booking Service 2021-03-08T05:17:54Z healthengine-chosen-to-build-the-commonwealth-booking-platform-as-part-of-the-covid-19-vaccination-information-and-booking-service Perth, 8  March 2021 --  HealthEngine has joined the national COVID-19 vaccination rollout effort after being selected by the Australian Government Department of Health to build the Commonwealth booking platform as part of the COVID-19 Vaccination Information and Booking Service. The platform will be launched by the federal government in the coming weeks to support the multi-phased vaccination rollout as part of the DoH’s end-to-end COVID-19 vaccination solution that will allow patients to locate and book appointments with designated vaccine clinics via a Service Finder based on the HealthDirect-run National Health Services Directory (NHSD).   The Commonwealth booking platform will be available to approved health service providers who are part of the national COVID-19 vaccine rollout including GP clinics, pharmacies and State-run vaccination clinics. The HealthEngine designed solution is suitable as a standalone booking option that complies with government requirements around accessibility, privacy and security. This option will help clinics to ‘get online’ quickly for COVID vaccinations, where they don’t already have an online booking system. Clinics with existing booking systems are encouraged to continue using their systems, to leverage the benefits of a fully integrated booking system. This work builds on HealthEngine’s experience as a pioneer of healthcare online bookings in Australia with a robust and scalable system being developed by modifying HealthEngine’s proven platform. It’s being fast tracked to meet challenging deadlines to contribute to the DoH’s greater COVID management effort.  “Given the very tight timeframes involved and the complexity of such a project, we are under no illusions about the challenge we have signed up to. However,  the opportunity to support a historic public health effort involving millions of Australians by assisting the Federal government with a very important piece of national digital health infrastructure, was one we simply couldn’t pass up,” said Dr Marcus Tan, HealthEngine CEO, founder and medical director.   “We’re honoured to be selected by the Department of Health for the job.”  Dr Tan said, “We were humbled by and grateful for the tremendous support we received from the broader health and technology sectors with our bid to perform this work.   These included written references from practice customers large and small across the spectrum of health specialties, organisations that confirmed our patient-centred approach and our ability to cooperatively work with ecosystem partners such as Medipass and MedAdvisor to extend future functionality as required.  This project is a huge team effort and we’re excited to be an official part of the team.”   -end- About HealthEngineHealthEngine is Australia’s largest consumer healthcare network and the #1 go-to for healthcare bookings. Founded in 2006, HealthEngine is on a mission to transform Australia’s healthcare by making it easier for people to connect with their healthcare providers online and for health practitioners to deliver a great patient experience through technology. More than 9 million people across Australia have made more than 47 million bookings on the platform. To find, book and manage medical and dental appointments, visit For healthcare providers, please visit to learn more and join Australia’s largest network of patients. ELDO at the Forefront of Manufacturing Wet & Dry Wipes & Masks 2021-02-26T20:51:33Z eldo-at-the-forefront-of-manufacturing-wet-amp-dry-wipes-amp-masks By the end of 2019, China was facing the threat of COVID-19, and the family firm, ELDO decided to establish the face mask lines. Due to their good relationship and resources on the non-woven field, three fully automatic lines were built in a very short time. Each line daily output is around 120,000pcs. However, the face mask business is not only built to fight against COVID-19, ELDO’s mission is to expand the wipe business and to be the most professional and reliable wipe factory in China.    As the coronavirus disease 2019 (COVID-19) pandemic progressed, one debate raged on as to the use of face masks by individuals in the community. People often wear masks to protect themselves, but it is suggested that a stronger public health rationale is source control to protect others from respiratory droplets. This approach is important because of possible asymptomatic transmissions.     There are mechanistic reasons for covering the mouth to reduce respiratory droplet transmission and, indeed, cough etiquette is based on these considerations and not on evidence from clinical trials.    Over 20 years ELDO’s business has grown through providing a very high level of service, quality and dedication to their customer needs, and their comprehensive range of products saves you time and money and enables you to buy from one supplier. They now supply their high-quality products around 1000 containers annually to more than 55 countries.     Finally, mass masking is underpinned by basic public health principles that might not have been adequately appreciated by authorities or the public. First, controlling harms at source (masking) is at least as important as mitigation (handwashing). The population benefits of mass masking can also be conceptualised as a so-called prevention paradox—ie, interventions that bring moderate benefits to individuals but have large population benefits.    The ELDO team look forward to offering you their outstanding service in the near future, and for more information on single use wet wipes, protective face masks and disposable latex gloves please go to .   Microba Life Sciences joins renowned Microbiome Therapeutics Innovation Group to drive life-saving therapeutics forward 2021-02-22T23:39:52Z microba-life-sciences-joins-renowned-microbiome-therapeutics-innovation-group-to-drive-life-saving-therapeutics-forward AUSTRALIA - Leading biotech Microba Life Sciences has joined the ranks of prominent microbiome therapeutic, biopharmaceutical and bioscience companies as a new member of the Microbiome Therapeutics Innovation Group (MTIG). Microba’s commitment to developing life-changing therapeutics derived from the gut microbiome will add a valuable voice to MTIG’s mission of accelerating microbiome therapeutic development to advance medicine. The addition of Microba brings MTIG’s membership to six companies pursuing regulatory approvals for microbiome therapeutics and microbiome-based products, as well as a new voice in Microba’s CEO Blake Wills as a new Director of MTIG’s Board. A leader in gut microbiome analysis and precision microbiome science, Microba’s expertise in combining accurate measurement of the gut microbiome with a human-first, data-driven approach to therapeutic discovery is being used to develop microbiome-derived treatments as new solutions to human health problems. Joining other members Seres Therapeutics, Rebiotix, Siolta Therapeutics, Takeda and Vedanta Biosciences, Microba will add to the collective voice of the group which aims to address unmet clinical needs, improve clinical outcomes and reduce healthcare costs. Leveraging the status of the human microbiome as a new frontier in medical innovation, MTIG is an independent coalition of companies lending their voice to research and development of FDA-approved microbiome therapeutics and microbiome-based products. “At Microba, our mission is to develop life-enhancing therapeutics to progress medicine by harnessing the microbiome as a rich source of novel therapeutics,” said Blake Wills, Microba CEO. “Our core belief is that comprehensive and precise measurement of the human gut microbiome and our unique approach to genome-directed isolation are integral in driving new opportunities.” Chairman of MTIG, Dr Ken Blount, PhD, said that Microba’s addition to MTIG would assist in their mission to advance health globally through innovative microbiome therapeutics. “Microba Life Sciences brings a unique viewpoint as a pre-clinical biotech utilizing an innovative, data-focused approach to identifying therapeutic discoveries,” he said. “We welcome their efforts as we seek to advance the regulatory field for microbiome therapeutics.”   Ends. Gold Coast's prominent hypnotherapy practice, Moving Minds Hypnotherapy wins the 2021 ThreeBestRated® award 2021-02-19T05:29:58Z gold-coast-s-prominent-hypnotherapy-practice-moving-minds-hypnotherapy-wins-the-2021-threebestrated-award-1 Gold Coast 19/02/2021 - Moving Minds Hypnotherapy, one of the most sought after hypnotherapy practices in Gold Coast, Queensland, has won the prestigious 2021 ThreeBestRated® award. Moving Minds Hypnotherapy has been a recipient of this award for more than four times. Each year ThreeBestRated® review team conducts a rigorous 50-point inspection to rate and list the top three hypnotherapy practices on their website. Reviews, ratings, reputation, history, complaints, satisfaction, trust, cost, general excellence, etc., of the hypnotherapy practice, are evaluated using the 50-point inspection before honouring them with the award. "We are very proud to say we have been recognised on the 'ThreeBestRated®' website's list since 2017 and are sitting in the first position, for the last three years. Many people self-proclaim to be the best. But to be acknowledged by an independent, non-biased agency who also has the intention of serving the public is something we take great pride in.", said Greg Thompson, founder of Moving Minds Hypnotherapy. Moving Minds Hypnotherapy's achievement of being the best didn't happen overnight. Their remarkable journey started in 2015. Greg Thompson, the lead hypnotherapist, established Moving Minds Hypnotherapy with an aim to serve the needs of the communities of Gold Coast through hypnosis. Over the years, Greg has helped thousands of people with anxiety, depression, and weight-loss, as well as habits and addictions such as smoking, alcohol, and drugs. Greg has led his clinic to grow into a trusted practice to overcome emotional and behavioural issues. The Team In 2020, Greg Thompson added two additional hypnotherapists to his team. Both of which are trained to the highest standards. They are accredited by both the Australian Hypnotherapists Association (AHA) and The Hypnotherapy Council of Australia (HCA). The team of professionals continues to be mentored by Greg in the practice of helping people heal, grow, and overcome limiting beliefs and behaviours. All of their team members at Moving Minds Hypnotherapy are fascinated with the power of the mind and are passionate about being a force for good in the world. They said, "We feel lucky to be the people that can facilitate positive changes that often feel impossible for our clients. To see someone walk into our office crippled by anxiety or depression and has tried absolutely everything else to no avail, leave our office only an hour later, totally transformed. There are no words to describe the appreciation we feel in knowing that this is the work we do!" The Moving Minds hypnotherapists understand that everyone is different and so they tailor-adjust traditional clinical hypnotherapy and conversational hypnotherapy to get the absolute best result for their clients. They are transforming the lives of so many people across Australia through hypnosis. CONTACT INFORMATION Moving Minds Hypnotherapy Suite 1 West Wing, 2 Fortune St,  Coomera, QLD 4209 Phone: 0422 741 041 E-mail: Website: Vitalcare and Checked In Care partner to improve home care services 2021-02-16T06:38:09Z vitalcare-and-checked-in-care-partner-to-improve-home-care-services Checked in Care (CiC), the leading customer experience self-service app platform, and Vitalcare, Australia’s most trusted brand in personal emergency response services, have partnered to drive their joint visions of enabling Ageing in Place.   “Checked in Care’s underlying philosophy is to enable a better quality of life, more cost-effectively, through the innovative use of technology. The Vitalcare partnership is a major step forward in enabling seniors to age in place, at the location of their choosing” notes John Perkins, CEO of Checked in Care. “A major concern of families is whether Mum or Dad is okay, whereas the seniors wish to know that when they need help, it is at hand via a single button push. With Vitalcare’s Rosie service on the Checked in Care platform, we make this happen.”   “Enhancing communications and care, and helping to improve the lives of seniors, their families, and care teams is our mission, which is so important when so many people feel disconnected. Vitalcare is proud to partner with Checked in Care to enable better connection and quality of life for seniors. Through this partnership, clients will receive a wide range of services and support that will assist them to remain independent and safe at home, even in an emergency,” says Logan Ross, Managing Director of Vitalcare.   Together, the partnership will help family and friends better care for their loved ones who live on their own, or those who live remotely. Through the CiC app platform, the family will receive ongoing notifications about their loved ones’ wellbeing and receive alerts when their loved one’s activity declines. “With Vitalcare, we have enabled a soft button on senior’s smart devices, that will make a call to Vitalcare’s 24/7 monitoring centre, giving seniors, and their families peace of mind that help is at hand, when required”, further notes John Perkins.   “Vitalcare always put clients at the heart of its operations and is dedicated to providing quality care at any time of the day or night. Having access to Checked in Care’s simple to use app, connected to Vitalcare’s 24/7 monitoring service will help clients and their loved ones feel safe and cared for at home, providing peace of mind for everyone,” also adds Logan Ross.   Logan Ross says, “Together, we will continuously develop solutions that will integrate a broader range of services to deliver person-centred experiences and quality health outcomes in the future.”   Checked in Care and Vitalcare’s solution can support ageing in place and improve seniors’ quality of life, whilst reducing the cost of care across a wide range of NDIS, Home Care and Residential Aged Care Facility operations. Novamind Announces Strategic Investment in Bionomics to Support PTSD Clinical Trial 2021-02-11T15:01:20Z novamind-announces-strategic-investment-in-bionomics-to-support-ptsd-clinical-trial      Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment TORONTO, Feb 11, 2021 - (ACN Newswire) - Novamind Inc. (CSE:NM) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has made a strategic investment of AU$827,486 (approximately CAN$810,000, the "Strategic Investment"), in Bionomics Limited ("Bionomics") (ASX:BNO)(OTCQB:BNOEF) (Germany:AU000000BNO5), a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders.In addition, Cedar Clinical Research ("CCR"), a wholly owned subsidiary of Novamind based in Springville, Utah, will be evaluated by Bionomics as a clinical research site to conduct Bionomics' Phase IIb trial examining BNC210. BNC210 has received Fast Track Designation from the U.S. Food and Drug Administration for the treatment of post-traumatic stress disorder (PTSD).With its investment in Bionomics, Novamind joins a group of well-known investors that specialize in psychedelics and biotech: Apeiron Investments, Biotech Value Fund, Merck & Co., Mike Novogratz, and Peter Thiel, an early investor in ATAI Life Sciences.Novamind's Strategic Investment is included in Bionomics' latest round of financing, which was underwritten by Apeiron Investments and received commitments for AU$16,000,000 (approximately CAN$15,680,000, the "Bionomics Financing"). Novamind will purchase a total of 5,706,800 common shares in the Bionomics Financing, at AU$0.145 per share, a 20% discount to the 30-day volume weighted average price as of February 5th, 2021. Proceeds from the Bionomics Financing will support the initiation of a Phase IIb trial for BNC210, planned for mid-2021.Bionomics intends to evaluate Cedar Clinical Research's deep expertise in facilitating Phase I to Phase IV clinical trials for leading pharmaceutical companies, and how it may potentially serve as a research site for Bionomics' Phase IIb clinical trial examining BNC210 in PTSD patients.Cedar Clinical Research, led by Novamind's Chief Medical Officer, Dr. Reid Robison, is currently contracted for seven clinical trials with various sponsors, including leading pharmaceutical companies. Dr. Robison has led over 100 clinical trials in neuropsychiatry, researching a spectrum of psychiatric conditions, including PTSD."I'm happy to welcome Novamind as a strategic investor in Bionomics," said Dr. Errol De Souza, Executive Chairman of Bionomics. "Dr. Robison and the team at Cedar Clinical Research have unique experience related to clinical trials for mental health therapeutics."Yaron Conforti, CEO and Director of Novamind, added, "We are pleased to participate in Bionomics' financing to support the development of its novel drug candidate for the treatment of PTSD. Cedar Clinical Research has unique expertise in PTSD research, and we look forward to the opportunity to contribute to the development of BNC210."To learn more about Cedar Clinical Research, please visit BionomicsBionomics is a global, clinical stage biopharmaceutical company leveraging its proprietary platform technologies to discover and develop a deep pipeline of best in class, novel drug candidates. Bionomics' lead drug candidate BNC210, currently in development for initiation of a second Phase II trial for the treatment of PTSD, is a novel, proprietary negative allosteric modulator of the alpha-7 nicotinic acetylcholine receptor. Beyond BNC210, Bionomics has a strategic partnership with Merck & Co., Inc (known as MSD outside the United States and Canada). To learn more, please visit NovamindNovamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit InformationNovamindYaron Conforti, CEO and DirectorTelephone: +1 (647) 953 9512Bill Mitoulas, Investor RelationsEmail: bill@novamind.caForward-Looking StatementsThis news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations including the risks detailed from time to time in the Company's public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.SOURCE: Novamind Inc.